Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Oral Signs of Systemic Disease: The Hospitalized Patient
Description
The presentation discusses oral signs of systemic diseases, particularly in hospitalized patients, highlighting the significance of mucosal symptoms in diagnosing conditions such as infections, drug reactions, and autoimmune diseases. The speaker categorizes mucosal diseases into infectious, drug-induced, metabolic, inflammatory, and malignancies. Clinical manifestations noted include labial swelling, ulcerations, and erosions in various oral locations, presenting challenges in diagnosis since many conditions share similar appearances. Importance is placed on thorough patient histories, particularly regarding previous mucosal diseases or medication changes, and the necessity of accurate HSV testing. The implications of viral conditions like erythema multiforme (EM) are explored, especially in major forms that involve the oral mucosa alongside dermatological manifestations. Various mimicking conditions are examined, such as reactive infectious mucotinous eruptions (Rhyme), differences between toxic erythemas and graft-versus-host disease (GVHD), emphasizing the nuances in clinical presentation and laboratory findings, including the CD8/CD4 cell ratio. Through specific case studies, the presentation illustrates the complexity of diagnosing overlapping dermatological and systemic conditions in patients, calling attention to the critical need for careful evaluation to inform treatment strategies and improve patient outcomes.
View moreConclusions
- Hospitalized patients often present with mucosal conditions that can signify underlying systemic diseases.
- Key categories for inpatient mucosal diseases include infections, medications, metabolic disorders, inflammatory processes, and malignancies.
- Differentiation of mucosal diseases is essential, relying on thorough clinical histories, systemic symptoms, and dermatological evaluations.
- Herpes Labialis (HSV) should be routinely sampled as it may frequently co-occur in patients with mucosal lesions.
- Erythema Multiforme (EM) can present with significant mucosal involvement, particularly with major forms affecting the oral cavity.
- Mycoplasma pneumoniae can induce mucositis resembling severe cutaneous conditions like EM and SJS/TEN, necessitating a focus on infectious triggers.
- Rowell syndrome, characterized by distinct clinical and serological findings, can mimic both systemic lupus erythematosus and EM.
- The presence of eosinophilia, transaminitis, and specific pustule morphology assists in distinguishing between AGEP and DRESS syndrome.
- Mucosal symptoms are prevalent in conditions such as generalized bullous fixed drug eruptions, indicating a need for prompt recognition and management.
- Understanding the CD8/CD4 T-lymphocyte ratio can aid in differentiating between SJS/TEN and GVHD to improve patient outcomes.
- Accurate diagnosis hinges not only on clinical presentation but also on recognizing the systemic implications of mucosal signs.
- C Johnston and A Wald. Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection. Uptodate. Accessed Mar 12, 23.
- Dalipi Zana Silamniku, et al. Case Rep Dent. Aug 2021.
- Theresa N Canavan et al. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015 Feb;72(2):239-45. doi: 10.1016/j.jaad.2014.06.026.
- Ander Mayor-Ibarguren et al. Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae-Induced Rash and Mucositis Concept. Pediatr Dermatol. 2017 Jul;34(4):465-472. doi: 10.1111/pde.13140. Epub 2017 Jun 1.
- Wahbi Ben Salha et al. Erosive cheilitis as an early manifestation in DRESS. Clin Case Rep. 2021 Nov 22;9(11):e05123. doi: 10.1002/ccr3.5123.
- Yuri Ueharaguchi et al. Multiple follicular pustules as an atypical cutaneous manifestation of drug-induced hypersensitivity. Acta Derm Venereol. 2011 Oct;91(6):728-9. doi: 10.2340/00015555-1152.
- S Lipowicz et al. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2013 Apr;168(4):726-32. doi: 10.1111/bjd.12133.